Document:

Exhibit 10.4

    

    

    Gain Therapeutics, Inc.

    4800 Hampden Lane Suite 200

    Bethesda, MD 20814

    

    

    July 8, 2020

    

    

    Eric Richman

    (via email eirichman@gaintherapeutics.com)

    

    

    Dear Eric:

    

    

    Gain Therapeutics, Inc. (the “Company”) is pleased to offer you the position of Chief Executive Officer of the Company on the following terms:

    

    

    1.          Position.

     

    

    (a)          You will be employed as Chief Executive Officer (“CEO”) of the Company and you will report to the Company’s Board of Directors (the “Board”). This is a full-time position. 
      By signing this letter agreement, you confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company. During the term of your employment, you shall also
      serve, without additional compensation, as a member of the Board for the term of your employment as CEO.

    

    

    
      (b)          You agree to the best of your ability and experience that you will at all times loyally and conscientiously perform all of the duties and obligations required of and from you pursuant
        to the express and implicit terms hereof, and to the reasonable satisfaction of the Company.  During your employment, you further agree that you will devote all of your business time and attention to the business of the Company, the Company will be
        entitled to all of the benefits and profits arising from or incidental to all such work services and advice, you will not render commercial or professional services of any nature to any person or organization, whether or not for compensation,
        without the prior written consent of the Company, and you will not directly or indirectly engage or participate in any business that is competitive in any manner with the business of the Company.  Nothing in this letter agreement will prevent you
        from accepting speaking or presentation engagements in exchange for honoraria or from serving on boards of charitable organizations or public or private corporations that are not competitive in any manner with the business of the Company (current
        relationships in exhibit A), or from owning no more than one percent (1%) of the outstanding equity securities of a corporation whose stock is listed on a national stock exchange.

      

      

    

    2.          Start Date.  Subject to fulfillment of any conditions imposed by this letter agreement, you will commence this new position with the Company
      effective July 20, 2020 and will be effective for a period of two years thereafter.

    

    

    3.          Proof of Right to Work.  For purposes of federal immigration law, you will be required to provide to the Company satisfactory documentary proof
      of your identity and eligibility for employment in the United States, and this offer is contingent upon such satisfactory proof.  Such documentation must be provided to the Company within three business days of your date of hire.

    

    

    4.          Cash Compensation.  The Company will pay you a starting salary at the rate of $300,000 per year, less required deductions and withholdings,
      payable in accordance with the Company’s standard payroll schedule.  This salary will be subject to adjustment pursuant to the Company’s employee compensation policies in effect from time to time. As an exempt salaried employee, you will be expected
      to work hours as required by the nature of your work assignments, including hours beyond the Company’s normal business hours, and you will not be eligible for, nor entitled to receive, overtime compensation.

    
      
        

    

    
    In addition, you will be paid a signing bonus of $30,000 and eligible to be considered for a discretionary incentive bonus for each fiscal year of the Company. Whether you are awarded any bonus for
      a given fiscal year, and the amount of the bonus (if any), will be determined by the Company in its sole discretion based upon achievement of Company and personal objectives established and approved by the Company’s Board of Directors. The
      determinations of the Company’s Board of Directors with respect to your bonus will be final and binding.

    

    

    5.          Employee Benefits.  As a regular employee of the Company, you will be eligible to participate in a number of Company-sponsored benefits,
      including its medical, dental and 401(k) plans, under the terms and conditions of the benefit plans that may be in effect from time to time.  In addition, you will be entitled to 20 vacation days and to accrue and use paid vacation benefits, in
      accordance with the Company’s vacation policy, as in effect from time to time.

    

    

    6.          Confidential Information and Inventions Assignment/Company Policies.  Like all Company employees, you will be required, as a condition of your
      employment with the Company, to sign the Company’s standard Employee Confidential Information and Inventions Assignment Agreement, a copy of which is attached hereto as Exhibit 1.  In addition, you will
      be expected to abide by Company rules and policies.

    

    

    7.          Employment Relationship.  Your employment with the Company may be terminated by either you or the Company at any time and for any reason, with or
      without cause or advance notice.  Any contrary representations that may have been made to you are superseded by this letter agreement.  This is the full and complete agreement between you and the Company on this term.  Although your job duties,
      title, compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and a duly
      authorized officer of the Company (other than you).

    

    

    9.          Tax Matters.  All forms of compensation referred to in this letter agreement are subject to reduction to reflect applicable withholding and
      payroll taxes and other deductions required by law. You are encouraged to obtain your own tax advice regarding your compensation from the Company. You agree that the Company does not have a duty to design its compensation policies in a manner that
      minimizes your tax liabilities, and you will not make any claim against the Company or the Board related to tax liabilities arising from your compensation.

    

    

    10.          No Conflicting Obligations.  You understand and agree that by accepting this offer of employment, you represent to the Company that your
      performance will not breach any other agreement to which you are a party and that you have not, and will not during the term of your employment with the Company, enter into any oral or written agreement in conflict with any of the provisions of this
      letter or the Company’s policies.  You are not to bring with you to the Company, or use or disclose to any person associated with the Company, any confidential or proprietary information belonging to any former employer or other person or entity with
      respect to which you owe an obligation of confidentiality under any agreement or otherwise.  The Company does not want or need and will not use such information, will assist you to preserve and protect the confidentiality of proprietary information
      belonging to third parties, and expects you to use in performing your duties for the Company only information which is generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry
      or otherwise legally in the public domain, or which is otherwise provided or developed by the Company.  Also, we expect you to abide by any obligations to refrain from soliciting any person employed by or otherwise associated with any former employer
      and suggest that you refrain from having any contact with such persons until such time as any non-solicitation obligation expires.

    

    

    11.          Interpretation, Amendment and Enforcement.  This letter agreement, together with the Confidential
      Information and Inventions Assignment Agreement, constitutes the complete agreement between you and the Company, contains all of the terms of your employment with the Company and supersedes any prior agreements, representations or understandings
      (whether written, oral or implied) between you and the Company.  It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other agreements, promises,
      warranties or representations concerning its subject matter. Changes in the terms hereof, other than those changes expressly reserved to the Company’s discretion in this letter, require an express written modification signed by both you and a duly
      authorized officer of the Company.  The terms of this letter agreement and the resolution of any disputes as to the meaning, effect, performance or validity of this letter agreement or arising out of, related to, or in any way connected with, this
      letter agreement, your employment by the Company or any other relationship between you and the Company (the “Disputes”) will be governed by Delaware law, excluding laws relating to conflicts or choice of law.  You and the Company submit to the
      exclusive personal jurisdiction of the federal and state courts located in Delaware in connection with any Dispute or any claim related to any Dispute.

    

    

    * * * * *

    
      2

      
        

    

    We hope that you will accept our offer to join the Company.  You may indicate your agreement with these terms and accept this offer by signing and dating both the enclosed duplicate original of
      this letter agreement and the enclosed Confidential Information and Inventions Agreement and returning them to me.  This offer, if not accepted, will expire at the close of business on July 19, 2020.

    

    

    If you have any questions, please do not hesitate to contact me.

    

    

    Very truly yours,

    

    

    Gain Therapeutics, Inc.

    

    

    

    

    	By:

          	/s/ Shawn Titcomb

          	 
	 	Shawn Titcomb

          	 
	 	Director / Officer

          	 

    

    

    I have read and accept this employment offer:

    

    

    	
            /s/ Eric I. Richman

            

          	 

    Signature

    

    

    Printed Name:  Eric I. Richman

    

    

    Dated:

    

    

    July  8, 2020

    
      3

      
        

    

    Exhibit A

    

    

    InFuse Holdings – Founder and Chairman

    LabConnect – Chairman

    Neubase (NBSE) – Director

    Rev Capital II, LLC – Manager

    VerImmune, Inc. – Advisor

    Epidarex Capital – Advisor

    NovelStem, Inc. – Director

    Babson Diagnostics – AdvisorExhibit 10.5

    

    

    Lugano, August 13, 2020

    

    

    Re: Your employment at GT Gain Therapeutics SA, Lugano:

    

    

    Dear Dr. Bellotto:

    

    

    In accordance with our previous understandings, we wish to confirm that it is the intention of GT Gain Therapeutics SA,
      (hereinafter the "Company") to enter into this indefinite term employment agreement upon the terms and conditions hereinafter specified. This employment agreement effectively substitutes the previous one date
      Dec 1st 2018, which is to be considered void.

    

    

    1.          Duties — Place of work

    

    

    	

          	1.1	
            You will be employed by the Company as Executive, effective from September 1st, 2020, to perform the duties of "General Manager" of the Company on a full-time basis and
              reporting ultimately to the Chief Executive Officer of Gain Therapeutics Inc (hereinafter the "Parent Company").

          

    

    

    	

          	1.2	
            Your position implies that you may be appointed to corporate offices (e-g. director, managing director, chief financial officer, representative of a branch) in the Parent Company and/or
              other Gain Therapeutics Group companies. You hereby acknowledge that the compensation provided for under paragraph 2.1 below has been negotiated also in order to compensate any services rendered by you in the above corporate offices and
              therefore you shall not be entitled to any further or specific compensation for any such corporate offices.

          

    

    

    	

          	1.3	
            As an employee of the Company, you hereby undertake, for as long as you are employed, to devote your attention and ability to the duties of your employment, and faithfully and
              diligently perform your duties and exercise only such powers as are consistent with them. In particular, you shall (i) comply with all lawful and reasonable directions given by the Chief Executive Officer of the Parent Company or the
              persons/committees delegated by the Chief Executive Office of the Parent Company, (ii) use your reasonable endeavours to promote the interests of the Company and (iii) keep the Chief Executive Officer of the Parent Company informed (in
              writing if so requested) of your conduct of business and provide such explanations as they may reasonably require.

          

    

    

    	

          	1.4	
            You will be based in the office of GT Gain Therapeutics SA located in Via Pietro Peri 9D, Lugano which is your primary working place. The fulfilment of your responsibilities may also
              make it necessary for you to travel abroad.

          

    

    

    2.          Compensation

    

    

    	

          	2.1	
            As compensation for the services rendered in favour of the Company, you will receive a base salary of CHF 200,000.00 (hereinafter the "Base Salary"), gross of any applicable tax and
              social security withholdings. Your Base Salary shall be reviewed annually by the Chief Executive Officer of the Parent Company and in light of such review may be increased (but not decreased) taking into account any change in your
              responsibilities, your performance and any other factors the Board of Directors and President deems relevant.

          

    

    

    	

          	2.3	
            The Base Salary will be paid in 12 (twelve) monthly instalments, gross of any applicable tax and social security withholdings to be paid on the 26th day of each month.

          

    

    

    
      

      1

      
        

      

    

    

    

    	

          	2.4	
            You hereby undertake not to disclose and keep confidential the terms of your economic treatment. You hereby waive any privacy or confidentiality
              rights you may have if the Company is required to or chooses to disclose, including publicly, the terms of your economic treatment, including fling this Agreement as an exhibit to its registration statements or reports filed with the
              Securities and Exchange Commission, other regulators and/or any securities exchange upon which the Company's securities are listed or traded.

          

    

    

    3.          Fringe Benefits

    

    

    	

          	3.1	
            The Company will provide you with a laptop and mobile phone for the performance of your duties. In case you decide to use your personal mobile
              phone the Company will recognize a fixed monthly reimbursement of CHF 100. In such case you will be entitled to use such phone also for private purposes in accordance with the Company's internal regulation in its respective relevant version
              and in compliance with the applicable tax and social security regulations in force in Switzerland.

          

    

    

    	

          	3.2	
            You will be eligible for all general employee benefit plans and programs provided to all employees of the Company, including improvements or
              modifications of the same.

          

    

    

    4.          Bonus

    

    

    	

          	4.1	
            You may be eligible to receive an annual bonus in cash (hereinafter, the "Bonus") in accordance with
              the Company's internal rules as applied from time to time, targeted at 30% of your Base Salary, upon achievement of the objectives to be determined by the Chief Executive Officer of the Parent Company.

          

    

    

    	

          	4.2	
            All bonuses will be awarded at the sole discretion of the Company. Therefore, the granting of a Bonus in a given year will not entitle you to
              receive the Bonus in the following years.

          

    

    

    	

          	4.3	
            You shall be eligible to participate in a stock option plan and entitles to receive an amount of stock option of 1.5% in the Parent Company
              capital and according to the terms and conditions of the related incentive plan reserved to employees, consultants and collaborators. At any time that the Parent Company capital increases, you will be entitled to receive additional grants so
              that your options pool will be not less than 1.5% of the Company's valuation.

          

    

    

    5.          Working time

    

    

    	

          	5.1	
            In light of the particular duties pertaining to your employment relationship, you shall not be subject to a specific working time (the average of
              40 hours weekly working time shall be a guideline) and, therefore, you shall not be entitled to any further compensation in addition to your Base Salary, nor you shall be entitled to specific pay for overtime. In any case, you undertake to
              commit 100% of your professional time to the services to be rendered in favour of the Company pursuant to this agreement.

          

    

    

    6.          Term

    

    

    	

          	6.1	
            Your employment relationship shall be effective from September 1st, 2020 and shall be deemed for an indefinite term, commencing from the date
              hereof.

          

    

    

    
      

      2

      
        

      

    

    7.          Duty of loyalty, confidentiality and other
        duties

    

    

    	

          	7.1	
            During the performance of your employment relationship with the Company, you undertake not to engage in any activities, directly or indirectly, which can be deemed in violation of your
              duty of loyalty towards the Company including - whether alone or jointly with any other person, company or entity, and whether directly or indirectly, and whether as director, officer, agent, promoter, manager, employee or consultant of, in
              or to any other person, company or entity - carrying out any activities in projects in competition with the business of the Company. Limited time consulting on projects not in direct competition is allowed, a list of the ongoing activities
              that are allowed is attached as Annex 1.

          

    

    

    	

          	7.2	
            You shall not, at any time - whether during the term of the employment with the Company or after its termination, for any reason - divulge to any other entity or person any confidential
              information concerning the Company's financial affairs or business processes or methods or its research, development or marketing programs or plans, any of its trade secrets, any of its customers and suppliers. You acknowledge that all
              information, the disclosure of which is prohibited under these provisions, is of a confidential and proprietary character and of great value to the Company.

          

    

    

    	

          	7.3	
            You further agree to deliver promptly to the Company, upon termination of the employment with the Company for any reason, or at any time that the Company may so request, all
              confidential memoranda, notes, records, reports, manuals, drawings, software, electronic/digital media records, and other documents (and all copies thereof) relating to the Company's business and all property associated therewith, which you
              may then possess or have under your control.

          

    

    

    8.          Restrictive covenants

    

    

    	

          	8.1	
            You hereby further covenant and undertake to the Company that you will not:

          

    

    

    	

          	(i)	
            solicit, approach or entice away from the Company any officer, employee, consultant or agent whether or not that person would commit a breach of his/her employment/ consultancy/agency
              agreement by reason of leaving service;

          

    

    

    	

          	(ii)	
            canvass, solicit, approach or entice away from the Company any person/company who is a customer of the Company;

          

    

    

    	

          	(iii)	
            canvass, solicit, approach or entice away from the Company any person/company who/which supplied good or services to the Company during the performance of your employment relationship,
              or interfere or seek to interfere or take steps which may interfere with supplies to the Company or with the terms of business relating to such supplies.

          

    

    

    
      	

            	8.2	
              It is understood that you cannot carry out any of the activities under paragraph 8.1 above whether directly or indirectly, whether alone or jointly with any other person, company or
                entity, and whether as shareholder, director, manager, officer, employee, agent, promoter, consultant of, in or to any other person, company or entity.

            

    

    

    

    
      
        	

              	8.3	
                You shall procure that, except as provided for under paragraph 8.1 above, no entity owned or controlled directly or indirectly by you (whether alone or together with one or more
                  persons) will act in such a way as would be a breach of the obligations contained in this Section 8 if you were so to act.

              

      

    

    

    

    9.          Business travel

    

    

    	

          	9.1	
            You are entitled to obtain reimbursement of the relevant out of pocket expenses borne in connection with performance of business travels, upon delivery of the pertinent documentation, which has to be in compliance with the applicable tax regulations and Company's policy in its respective relevant version.

          

    

    

    
      

      3

      
        

      

    

    10.          Holidays

    

    

    	

          	10.1	
            You are entitled to an annual paid vacation period equal to 25 (twenty-five) business days that may be carried over from year-to-year. You shall be entitled to a cash payment for any
              unused paid time off days.

          

    

    

    11.          Termination

    

    

    	

          	11.1	
            Each of the parties may terminate the employment relationship for the reasons and following the procedures set forth in statutory provisions and in the applicable law.

          

    

    

    	

          	11.2	
            Employment may be terminated by either party as of the end of the month, with a notice period of six months. Notice must in any case be given in writing.

          

    

    

    	

          	11.3	
            After termination of the employment relationship you are bound by the restrictions as set out by law or in this employment agreement, your duty of confidentiality according to clause
              7.2 of this agreement persist without limitation during the notice period as well as for the time after termination of this employment relationship.

          

    

    

    	

          	11.4	
            Upon termination of your employment relationship, irrespective of the reason thereto, you shall be obliged to return all material and property belonging to the Company.

          

    

    

    	

          	11.5	
            Upon termination of your employment relationship, irrespective of the reason thereto, you shall be entitled to (a) all accrued but unpaid Base Salary and benefits up to and including
              the date of termination, or, in the case of your death, accrued to the last day of the month in which the death occurs, (b) exercise your vested options to purchase ordinary shares of the Company in accordance with the terms set forth herein,
              except in the case of your death or disability, in which case you or your estate, as applicable, shall have the right to exercise all vested options, at a minimum, during the one year period from the date of death or disability, and (c) any
              payment owed or due to you, but not yet paid, pursuant to your Bonus.

          

    

    

    	

          	11.6	
            Where a Change In Control occurs (as defined below) and/or your employment is terminated by the Company without Cause (as defined below) or you resign within 24 months of the date of
              the Change In Control and/or for Good Reason (as defined below), you will be entitled to receive, severance pay equal to (a) an amount equal to the aggregate of (i) 2.0 times your annual Base Salary in effect at such time of termination, (ii)
              2.0 times the greater of the average of the Bonuses received in the last 3 years of employment or the targeted Bonus for the year in which you are terminated or resign and (iii) the prorated targeted Bonus for the year in which you are
              terminated or resign as accrued in the course of the year of termination or resignation. In addition, in such a situation, all your unvested stock options will become fully vested and exercisable of the date of termination or resignation of
              employment and shall be exercisable for a period of 90 days after the date of termination or resignation. Finally, you shall be entitled to reimbursment of any legal expenses incurred in the course of enforcing amounts due under the paragraph
              11.6

          

    

    

    	

          	11.7	
            Should you elect to receive the severance payment referred to in paragraphs 11.6 above, no further sum shall be due and payable by the Company including but not limited to the notice
              period indemnity and the other indemnities and damages as well as any damages whatsoever. The payment of the relevant severance will be conditioned upon the execution by you of a waiver and release in the form established by the Company.

          

    

    

    
      

      4

      
        

      

    

    13.          Definitions

    

    

    "Change In Control" shall mean:

    

    

    	

          	(a)	
            The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if more than 50% of the combined voting power of the
              continuing or surviving entity's securities outstanding immediately after such merger, consolidation or other reorganization is owned by persons who were not shareholders of the Company immediately prior to such merger, consolidation or other
              reorganization;

          

    

    

    	

          	(b)	
            The date a majority of members of the Board is replaced during any 12-month period with directors whose appointment or election is not endorsed by a majority of the members of the Board
              or a majority of the Directors then comprising the Nominating and Corporate Governance Committee before the date of the appointment or election (the "Incumbent Board"); provided, that any individual who was initially elected as a
              Director of the Company as a result of an actual or threatened election contest, as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act, or any other actual or threatened solicitation of proxies or consents
              by or on behalf of any Person other than the Board shall not be deemed a member of the Incumbent Board;

          

    

    

    	

          	(c)	
            The sale, transfer or other disposition of all or substantially all of the Company's assets;

          

    

    

    	

          	(d)	
            Any transaction as a result of which any person, or more than one person acting as a group becomes the beneficiary, owner and/or "beneficial owner" (as defined in Rule 13d-3 under the
              Exchange Act), directly or indirectly, (or has, during the twelve (12) month period ending on the date of the most recent acquisition by such person or group, become the beneficiary, owner and/or "beneficial owner," directly or indirectly) of
              securities of the Company representing at least 30% of the total voting power represented by the Company's then outstanding voting securities. For purposes of this Paragraph (c), the term "person" shall indicate any person and/or entity
              except for:

          

    

    

    	

          	(i)	
            A trustee or other fiduciary holding securities under an employee benefit plan of the Company or a subsidiary of the Company;

          

    

    

    	

          	(ii)	
            A corporation owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of Shares; and

          

    

    

    	

          	(iii)	
            The Company.

          

    

    

    "Termination for Cause" shall mean a termination by the Company when there is a cause triggering a termination
      without notice. By way of example, Cause shall mean any of the following: (i) your commitment of a felony or of any criminal act (not including traffic misdemeanors) involving moral turpitude which results in a conviction; (ii) your deliberate and
      continual refusal to perform satisfactorily in all material respects employment duties not inconsistent with this Agreement; (iii) an act of fraud or embezzlement by you; (iv) your wilful misconduct or negligence having a material adverse effect on
      the Company's business; or (v) a material breach of this Agreement, including the loyalty provisions set forth in Paragraph 8.1, the Company's code of conduct, the Company's code of ethics or the Company's insider trading policy. Determination as to
      whether or not a Cause exists for termination of the employment will be made in accordance with Swiss-laws.

    

    

    "Resignation with Good Reason" shall mean a resignation of the employment by you due to (i) a material breach by
      the Company of its obligations under this Agreement, (ii) a material diminution of your authority, duties or responsibilities (including status, offices, titles and reporting requirements) so as to qualify a demotion, (iii) a material reduction in
      your Base Salary.

    

    

    
      

      5

      
        

      

    

    14. Social security, tax at source and family allowances

    

    

    	

          	14.1	
            The premiums for social security insurances prescribed by statute as well as any state impositions (such as but not limited to source taxes) according to the applicable law are deducted
              from the salary payments and from any other payment subject to such deductions.

          

    

    

    	

          	14.3	
            If you are subject to the Swiss social security system, you are insured under the LAINF (Accident Insurance Law) against occupational accidents and against non-occupational accidents.
              The consequences of an accident are additionally covered by a complementary insurance (accident insurance in addition). The premiums for the occupational accident insurance are borne in full by the employer. The premiums for the
              non-occupational insurance and the complementary insurance are borne 50% by each party.

          

    

    

    	

          	14.4.	
            You are admitted to the Company's pension scheme, if you are subject to the Swiss social security system. In this case, the pension scheme benefits and the contributions to be paid are
              determined by the regulations in its respective relevant version.

          

    

    

    15.          Sickness and salary continuation

    

    

    Salary continuation in the event of sickness is governed by prescription of the law. In the event that the you are subject to the Swiss social security
      system, there exists an illness daily allowance insurance.

    

    

    The scope and term of the insurance benefits paid in this case are determined by the condition of the insurance contract in force at the time, whereby
      the premiums are borne 50% by each party. Benefits paid by the insurance supersede entitlements for salary continuation according to the prescriptions of the law. The premiums are borne by employee and employer 50% each.

    

    

    16.          Notice

    

    

    	

          	16.1	
            Any notice or other communication to be given under this Agreement shall be in writing and addressed as follows:

          

    

    

    for the Company:

    GT Gain Therapeutics SA

    Via Pietro Peri no. 9D 6900 Lugano, Switzerland

    

    

    for Dr. Manolo Bellotto

    Via Cortivo 2, 6976 Lugano-Castagnola, Switzerland

    

    

    0.          Governing law and Jurisdiction

    

    

    	

          	17.1	
            Any other terms and conditions of your employment not expressly regulated herein shall be governed by the applicable provisions of Swiss law, which governs this contract and the relevant employment relationship, and the jurisdiction is that of the competent courts of Lugano (Switzerland).

          

    

    

    
      

      6

      
        

      

    

    18          Final provisions

    

    

    	

          	18.1	
            This agreement is contingent upon issuance of the legally required permit authorizing the employee to perform work for employer in Switzerland.

          

    

    

    18.2          Amendments to this agreement can only be agreed upon in
        writing

    

    

    On behalf of GT Gain Therapeutics SA

    

    

    Dr. Lorenzo Leoni, Chairman

    

    

    Place and date, Lugano, 27 August 2020

    

    

    	
            /s/ Dr. Lorenzo Leoni

            

          	 
	
            Dr. Lorenzo Leoni

          	 

    

    

    

    

    For full acceptance of the above terms

    

    

    Dr. Manolo Bellotto

    

    

    Place and date, Lugano, 27 August 2020

     

    

    	
            /s/ Dr. Manolo Belletto

            

          	 

    

    

    

    

    
      

      7

      
        

      

    

    Annex 1: List of ongoing projects and companies with limited consulting activities

    

    

    	•	
            Mederis di Gaia Piraccini Bellotto, via Cortivo 2, CH-6976 Castagnola: Mederis is a service provider for pharmaceutical, medical device and medical food companies, biotech, academies
              and medical associations. Mederis offers services in the field of assessment, prioritization, planning and management of product development, medical and market-shaping activities.

          

    

    

  

  8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]